Compared with standard approaches, the BD vascular care solution reduced the relative risk of catheter failure by 27%, resulting in longer catheter dwell time without complications.
The use of 2% chlorhexidine (CHG) 70% isopropyl alcohol (IPA) single use, sterile pre-filled applicator skin antiseptic reduced the risk of infectious complications (catheter colonization and local infection) by 92% compared with 5% povidone iodine (PVI) 69% ethanol.
PIVCs are the most commonly used invasive medical devices in hospitals, where about 2 billion are placed annually worldwide2,3.
However, in hospitals, 35% to 50% of PIVCs do not meet their intended dwell time and need to be removed prematurely due to preventable complications, such as infection, occlusion, phlebitis, dislodgement and infiltration/extravasation2.
This can lead to longer hospital stays, higher inpatient costs, and great risk of death than patients without these preventable complications4.
In addition, unnecessary PIVC replacement can be painful to patients and lead to additional costs5, as well as have an effect on health care professionals’ ability to support other patients.
Bloodstream infections can have an even greater impact, by prolonging hospitalization and increasing treatment costs and mortality4.